OAM
XBIO icon

Oxford Asset Management’s Xenetic Biosciences XBIO Stock Holding History

Oxford Asset Management’s Portfolio XBIO Stock Details XBIO Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2020
Q1 		– Sell
-5,475
Closed -$79K – 1338
2019
Q4 		$79K Buy
+5,475
New +$69.5K ﹤0.01% 1639

Other funds holding XBIO

Renaissance Technologies
Renaissance Technologies New York $63.9B AUM 45.56% 1-Year Est. Return
SM
Sabby Management Miami Beach, Florida $45.1M AUM 74.25% 1-Year Est. Return
Royal Bank of Canada
Royal Bank of Canada Toronto, Ontario, Canada $570B AUM 27.57% 1-Year Est. Return
RE
RBC Europe London, United Kingdom $2.08B AUM 12.2% 1-Year Est. Return

Oxford Asset Management's XBIO Position: Q1 2020 in Review

Oxford Asset Management sold out of Xenetic Biosciences (XBIO) in Q1 2020, closing a stake of 5,475 shares — an estimated $79K sold.

Oxford Asset Management first reported a position in XBIO in Q4 2019 and held it in 1 quarter. The position peaked at $79K in Q4 2019. 8 funds tracked by Wall St. Rank hold XBIO as of Q1 2020.

  • Oxford Asset Management reported no remaining Xenetic Biosciences position as of Q1 2020 after selling out during the quarter.
  • Oxford Asset Management sold 5,475 Xenetic Biosciences shares in Q1 2020, an estimated $79K.
  • Oxford Asset Management first reported a position in Xenetic Biosciences in Q4 2019 and held it in 1 quarter.
  • Oxford Asset Management's Xenetic Biosciences position peaked at $79K in Q4 2019.
  • 8 funds tracked by Wall St. Rank held Xenetic Biosciences as of Q1 2020.

Based on Oxford Asset Management's 13F filing for Q1 2020, filed 15 May 2020.